This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2009.
Company Filing History:
1 out of 5,383 
1 out of 8,816 
Years Active: 2009
Title: Quentin Sattentau: Innovator in Anti-HIV Research
Introduction
Quentin Sattentau is a notable inventor based in Oxford, GB. He has made significant contributions to the field of medical research, particularly in the development of anti-HIV compositions. His work has the potential to impact the treatment of AIDS and improve the lives of many individuals affected by this virus.
Latest Patents
Sattentau holds a patent for an "Anti-HIV composition, production method thereof and medicament." This invention relates to a composition that includes a polyanion and a molecule capable of inducing the exposure of the CD4i epitope of the gp120 viral protein. The polyanion can be selected from substances such as heparin or heparan sulphate. The composition is intended for use in producing medicinal products aimed at treating AIDS.
Career Highlights
Throughout his career, Quentin Sattentau has worked with prestigious organizations, including the Commissariat à l'Énergie Atomique and the Centre National de la Recherche Scientifique. His experience in these institutions has contributed to his expertise in the field of virology and medicinal chemistry.
Collaborations
Sattentau has collaborated with notable colleagues, including Romain Vives and Claudio Vita. These partnerships have likely enhanced his research and development efforts in combating HIV.
Conclusion
Quentin Sattentau's innovative work in anti-HIV research exemplifies the importance of scientific advancements in the fight against viral infections. His contributions continue to pave the way for new treatment options for those affected by AIDS.